Edgewise Therapeutics, Inc.
EWTX
Revenue
0.00
0.000.00%
-Assets
552.60M
▼-30.86M▼-5.29%
3 Months ChangeLiabilities
30.35M
▲5.53M▲22.27%
3 Months ChangeFree Cash Flow
-28.90M
▼-1.70M▼-6.26%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001104659-26-020108
2025-11-20
Form 8-K
ID: 0001104659-25-114660
2025-11-10
Form 8-K
ID: 0001104659-25-109295
2025-11-06
Form 10-Q
ID: 0001104659-25-107427
2025-11-06
Form 8-K
ID: 0001104659-25-107419
2025-08-07
Form 10-Q
ID: 0001558370-25-010655
2025-08-07
Form 8-K
ID: 0001104659-25-074987
2025-06-26
Form 8-K
ID: 0001104659-25-063028
2025-05-08
Form 10-Q
ID: 0001558370-25-006857
2025-05-08
Form 8-K
ID: 0001104659-25-045896